ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
7.39
+0.04 (0.54%)
At close: Jan 28, 2026, 4:00 PM EST
7.39
0.00 (0.00%)
After-hours: Jan 28, 2026, 4:10 PM EST
ImageneBio Market Cap
ImageneBio has a market cap or net worth of $78.71 million as of January 28, 2026.
Market Cap
78.71M
Enterprise Value
-60.43M
1-Year Change
n/a
Ranking
Category
Stock Price
$7.39
Market Cap Chart
Since July 28, 2025, ImageneBio's market cap has decreased from $174.36M to $78.71M, a decrease of -54.86%. That is a compound annual growth rate of -79.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 78.28M | 6.52% |
| Dec 31, 2025 | 73.49M | -57.85% |
| Jul 28, 2025 | 174.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XBiotech | 81.10M |
| ALX Oncology Holdings | 80.24M |
| Pliant Therapeutics | 79.27M |
| Coeptis Therapeutics Holdings | 79.12M |
| Annovis Bio | 78.45M |
| Mereo BioPharma Group | 78.31M |
| PolyPid | 75.69M |
| Pelthos Therapeutics | 75.69M |